Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$188K Sell
1,766
-48
-3% -$5.81K 0.01% 1311
2026
Q1
$297K Buy
1,814
+141
+8% +$21.7K 0.01% 852
2025
Q4
$291K Buy
1,673
+506
+43% +$92.3K 0.01% 783
2025
Q3
$168K Buy
1,167
+367
+46% +$45K 0.01% 1101
2025
Q2
$80.5K Sell
800
-209
-21% -$16K 0.01% 1602
2025
Q1
$77K Buy
1,009
+386
+62% +$29.5K 0.01% 1465
2024
Q4
$43K Buy
623
+85
+16% +$6.12K ﹤0.01% 1779
2024
Q3
$39.3K Buy
538
+224
+71% +$16.5K ﹤0.01% 1670
2024
Q2
$21K Buy
314
+101
+47% +$3.92K ﹤0.01% 1822
2024
Q1
$5.78K Buy
213
+18
+9% +$504 ﹤0.01% 2347
2023
Q4
$5.42K Buy
+195
New +$5.06K ﹤0.01% 2202

Other funds holding INSM

GAMMA Investing's INSM Position: Q2 2026 in Review

GAMMA Investing reduced its Insmed (INSM) stake by 2.6% in Q2 2026, selling an estimated $5.81K and leaving 1,766 shares worth $188K. The position accounts for 0.01% of the portfolio, ranked #1311.

GAMMA Investing first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. The position peaked at $297K in Q1 2026. 79 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • GAMMA Investing held 1,766 shares of Insmed worth $188K as of Q2 2026.
  • GAMMA Investing sold 48 Insmed shares in Q2 2026, an estimated $5.81K.
  • Insmed made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1311 holding.
  • GAMMA Investing first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Insmed position peaked at $297K in Q1 2026.
  • 79 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.